Acute encephalitis in children: Progress and priorities from an Australasian perspective

Journal of Paediatrics and Child Health

Volumn 51, Issue 2, 2015, Pages 147-158

  Britton, Philip N ^a,b,c   Dale, Russell C ^a,b   Booy, Robert ^a,b,c   Jones, Cheryl A ^a,b,c  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c University of Sydney   (Australia)

Author keywords

aetiology; Asia; Australia; child; encephalitis; epidemiology

Indexed keywords

ACICLOVIR; ANTIINFECTIVE AGENT; CORTICOSTEROID; FOSCARNET; GANCICLOVIR; IMMUNOGLOBULIN;

AUSTRALIA; CLIMATE CHANGE; CLINICAL ASSESSMENT; ENCEPHALITIS; HERPES SIMPLEX ENCEPHALITIS; HERPES ZOSTER ENCEPHALITIS; IMMUNIZATION; IMMUNOPATHOLOGY; IMMUNOTHERAPY; PATHOGENESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; ACUTE DISEASE; AUSTRALIA AND NEW ZEALAND; CHILD; COMMUNICABLE DISEASE; HUMAN; IMMUNOLOGY; INCIDENCE; MICROBIOLOGY; PROCEDURES; RISK FACTOR; TRAVEL; VIROLOGY;

ACUTE DISEASE; AUSTRALASIA; CHILD; CLIMATE CHANGE; COMMUNICABLE DISEASES; ENCEPHALITIS; HUMANS; IMMUNOTHERAPY; INCIDENCE; RISK FACTORS; TRAVEL;

EID: 84922755747     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/jpc.12650     Document Type: Review

References (113)

1. Granerod J, Crowcroft NS,. The epidemiology of acute encephalitis. Neuropsychol. 2007; 17: 406-428.
2. Granerod J, Ambrose HE, Davies NW, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect. Dis. 2010; 10: 835-844. Erratum appears in Lancet Infect Dis. 2011 Feb;11(2):79.
3. Jmor F, Emsley HC, Fischer M, Solomon T, Lewthwaite P,. The incidence of acute encephalitis syndrome in Western industrialised and tropical countries. Virol. J. 2008; 5: 134-147.
4. Sejvar JJ, Kohl KS, Bilynsky R, et al. Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2007; 25: 5771-5792.
5. Glaser CA, Honarmand S, Anderson LJ, et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin. Infect. Dis. 2006; 43: 1565-1577.
6. Mailles A, Stahl J-P, Steering C, Investigators G,. Infectious encephalitis in france in 2007: a national prospective study. Clin. Infect. Dis. 2009; 49: 1838-1847.
7. Venkatesan A, Tunkel AR, Bloch KC, et al. Case Definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the International Encephalitis Consortium. Clin. Infect. Dis. 2013; 57: 1114-1128.
8. Solomon T, Hart IJ, Beeching NJ,. Viral encephalitis: a clinician's guide. Practical Neurol. 2007; 7: 288-305.
9. Granerod J, Tam CC, Crowcroft NS, Davies NWS, Borchert M, Thomas SL,. Challenge of the unknown. A systematic review of acute encephalitis in non-outbreak situations. Neurology 2010; 75: 924-932.
10. Mizuguchi M,. Acute necrotizing encephalopathy of childhood: a novel form of acute encephalopathy prevalent in Japan and Taiwan. Brain Dev. 1997; 19: 81-92.
11. Takanashi J,. Two newly proposed infectious encephalitis/encephalopathy syndromes. Brain Dev. 2009; 31: 521-528.
12. Casrouge A, Zhang SY, Eidenschenk C, et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 2006; 314: 308-312.
13. Granerod J, Cunningham R, Zuckerman M, et al. Causality in acute encephalitis: defining aetiologies. Epidemiol. Infect. 2010; 138: 783-800.
14. Rantala H, Uhari M,. Occurrence of childhood encephalitis: a population-based study. Pediatr. Infect. Dis. J. 1989; 8: 426-430.
15. Koskiniemi M, Rautonen J, Lehtokoski-Lehtiniemi E, Vaheri A,. Epidemiology of encephalitis in children: a 20-year survey. Ann. Neurol. 1991; 29: 492-497.
16. Cizman M, Jazbec J,. Etiology of acute encephalitis in childhood in Slovenia. Pediatr. Infect. Dis. J. 1993; 12: 903-908.
17. Kennedy CR, Chrzanowska K, Robinson RO, Tyrrell DA, Valman HB, Webster AD,. A major role for viruses in acute childhood encephalopathy. Lancet 1986; 1: 989-991.
18. Fowler A, Stodberg T, Eriksson M, Wickstrom R,. Childhood encephalitis in Sweden: etiology, clinical presentation and outcome. Eur. J. Paediatr. Neurol. 2008; 12: 484-490.
19. Galanakis E, Tzoufi M, Katragkou A, Nakou I, Roilides E,. A prospective multicenter study of childhood encephalitis in Greece. Pediatr. Infect. Dis. J. 2009; 28: 740-742.
20. Koskiniemi M, Korppi M, Mustonen K, et al. Epidemiology of encephalitis in children. A prospective multicentre study. Eur. J. Pediatr. 1997; 156: 541-545.
21. Ilias A, Galanakis E, Raissaki M, Kalmanti M,. Childhood encephalitis in Crete, Greece. J. Child Neurol. 2006; 21: 910-912.
22. Huttunen P, Lappalainen M, Salo E, et al. Differential diagnosis of acute central nervous system infections in children using modern microbiological methods. Acta Paediatr. 2009; 98: 1300-1306.
23. Beghi E, Nicolosi A, Kurland LT, Mulder DW, Hauser WA, Shuster L,. Encephalitis and aseptic meningitis, Olmsted County, Minnesota, 1950-1981: I. Epidemiology. Ann Neurol. 1984; 16: 283-294.
24. Lewis P, Glaser CA,. Encephalitis. Pediatr. Rev. 2005; 26: 353-363.
25. Kolski H, Ford-Jones EL, Richardson S, et al. Etiology of acute childhood encephalitis at The Hospital for Sick Children, Toronto, 1994-1995. Clin. Infect. Dis. 1998; 26: 398-409.
26. Glaser CA, Gilliam S, Schnurr D, et al. In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000. Clin. Infect. Dis. 2003; 36: 731-742.
27. Ishikawa T, Asano Y, Morishima T, et al. Epidemiology of acute childhood encephalitis. Aichi Prefecture, Japan, 1984-90. Brain Dev. 1993; 15: 192-197.
28. Wong V, Yeung CY,. Acute viral encephalitis in children. Aust. Paediatr. J. 1987; 23: 339-342.
29. Chokephaibulkit K, Kankirawatana P, Apintanapong S, et al. Viral etiologies of encephalitis in Thai children. Pediatr. Infect. Dis. J. 2001; 20: 216-218.
30. Srey VH, Sadones H, Ong S, et al. Etiology of encephalitis syndrome among hospitalized children and adults in Takeo, Cambodia, 1999-2000. Am. J. Trop. Med. Hyg. 2002; 66: 200-207.
31. Lee TC, Tsai CP, Yuan CL, et al. Encephalitis in Taiwan: a prospective hospital-based study. Jpn. J. Infect. Dis. 2003; 56: 193-199.
32. Ho Dang Trung N, Le Thi Phuong T, Wolbers M, et al. Aetiologies of central nervous system infection in Viet Nam: a prospective provincial hospital-based descriptive surveillance study. PLoS ONE [Electronic Resource] 2012; 7: e37825.
33. Xu Y, Zhaori G, Vene S, et al. Viral etiology of acute childhood encephalitis in Beijing diagnosed by analysis of single samples. Pediatr. Infect. Dis. J. 1996; 15: 1018-1024.
34. Le VT, Phan TQ, Do QH, et al. Viral etiology of encephalitis in children in southern Vietnam: results of a one-year prospective descriptive study. PLoS Negl. Trop. Dis. 2010; 4: e854.
35. Jones CA, Isaacs D, McIntyre P, Cunningham A, Garland S,. Neonatal herpes simplex virus infection. In:, Ridely G, Zurynski Y, Elliott EJ, eds. Australian Paediatric Surveillance Unit Research Report, 2007-8. Sydney: APSU, 2010; 24. ISSN: 1443-3524.
36. Kropp RY, Wong T, Cormier L, et al. Neonatal herpes simplex virus infections in Canada: results of a 3-year national prospective study. Pediatrics 2006; 117: 1955-1962.
37. Haddow LJ, Dave B, Mindel A, et al. Increase in rates of herpes simplex virus type 1 as a cause of anogenital herpes in western Sydney, Australia, between 1979 and 2003. Sex. Transm. Infect. 2006; 82: 255-259.
38. Bernstein DI, Bellamy AR, Hook EW 3rd, et al. Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clin. Infect. Dis. 2013; 56: 344-351.
39. Whitley RJ, Kimberlin DW,. Herpes simplex encephalitis: children and adolescents. Semin. Pediatr. Infect. Dis. 2005; 16: 17-23.
40. Steiner I, Kennedy PG, Pachner AR,. The neurotropic herpes viruses: herpes simplex and varicella-zoster. Lancet Neurol. 2007; 6: 1015-1028.
41. Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH,. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 2010; 10: 778-790.
42. Christie LJ, Honarmand S, Talkington DF, et al. Pediatric encephalitis: what is the role of Mycoplasma pneumoniae? Pediatrics 2007; 120: 305-313.
43. Bitnun A, Ford-Jones EL, Petric M, et al. Acute childhood encephalitis and Mycoplasma pneumoniae. Clin. Infect. Dis. 2001; 32: 1674-1684.
44. Amin R, Ford-Jones E, Richardson SE, et al. Acute childhood encephalitis and encephalopathy associated with influenza: a prospective 11-year review. Pediatr. Infect. Dis. J. 2008; 27: 390-395.
45. Wang GF, Li W, Li K,. Acute encephalopathy and encephalitis caused by influenza virus infection. Curr. Opin. Neurol. 2010; 23: 305-311.
46. Solomon T,. Recent advances in Japanese encephalitis. J. Neurovirol. 2003; 9: 274-283.
47. Centers for Disease C, Prevention. Japanese encephalitis surveillance and immunization-Asia and the Western Pacific, 2012. MMWR Morb. Mortal. Wkly Rep. 2013; 62: 658-662.
48. Koskiniemi M, Vaheri A,. Effect of measles, mumps, rubella vaccination on pattern of encephalitis in children. Lancet 1989; 1: 31-34.
49. Heinz FX, Stiasny K, Holzmann H, et al. Vaccination and tick-borne encephalitis, central Europe. Emerg. Infect. Dis. 2013; 19: 69-76.
50. Knox J, Cowan RU, Doyle JS, et al. Murray Valley encephalitis: a review of clinical features, diagnosis and treatment. Med. J. Aust. 2012; 196: 322-326.
51. Evans IA, Hueston L, Doggett SL,. Murray valley encephalitis virus. N. S. W. Public Health Bull. 2009; 20: 195-196.
52. Gray TJ, Burrow JN, Markey PG, et al. West nile virus (Kunjin subtype) disease in the northern territory of Australia-a case of encephalitis and review of all reported cases. Am. J. Trop. Med. Hyg. 2011; 85: 952-956.
53. Frost MJ, Zhang J, Edmonds JH, et al. Characterization of virulent West Nile virus Kunjin strain, Australia, 2011. Emerg. Infect. Dis. 2012; 18: 792-800.
54. Mahalingam S, Herrero LJ, Playford EG, et al. Hendra virus: an emerging paramyxovirus in Australia. Lancet Infect. Dis. 2012; 12: 799-807.
55. Playford EG, McCall B, Smith G, et al. Human Hendra virus encephalitis associated with equine outbreak, Australia, 2008. Emerg. Infect. Dis. 2010; 16: 219-223.
56. Samaratunga H, Searle JW, Hudson N,. Non-rabies Lyssavirus human encephalitis from fruit bats: Australian bat Lyssavirus (pteropid Lyssavirus) infection. Neuropathol. Appl. Neurobiol. 1998; 24: 331-335.
57. Hanna JN, Carney IK, Smith GA, et al. Australian bat lyssavirus infection: a second human case, with a long incubation period. Med. J. Aust. 2000; 172: 597-599.
58. Warrilow D,. Australian bat lyssavirus: a recently discovered new rhabdovirus. Curr. Top. Microbiol. Immunol. 2005; 292: 25-44.
59. Mackenzie JS, Williams DT,. The zoonotic flaviviruses of southern, south-eastern and eastern Asia, and Australasia: the potential for emergent viruses. Zoonoses Public Hlth. 2009; 56: 338-356.
60. Wender M,. Acute Disseminated Encephalomyelitis (ADEM). J. Neuroimmunol. 2011; 231: 92-99.
61. Young NP, Weinshenker BG, Lucchinetti CF,. Acute disseminated encephalomyelitis: current understanding and controversies. Semin. Neurol. 2008; 28: 84-94.
62. Dale RC, Brilot F, Banwell B,. Pediatric central nervous system inflammatory demyelination: acute disseminated encephalomyelitis, clinically isolated syndromes, neuromyelitis optica, and multiple sclerosis. Curr. Opin. Neurol. 2009; 22: 233-240.
63. Haberlandt E, Bast T, Ebner A, et al. Limbic encephalitis in children and adolescents. Arch. Dis. Child. 2011; 96: 186-191.
64. Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA,. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin. Infect. Dis. 2012; 54: 899-904.
65. Florance NR, Davis RL, Lam C, et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann. Neurol. 2009; 66: 11-18.
66. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008; 7: 1091-1098.
67. Vincent A, Buckley C, Schott JM, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004; 127 (Pt 3): 701-712.
68. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013; 12: 157-165.
69. Suleiman J, Brenner T, Gill D, et al. VGKC antibodies in pediatric encephalitis presenting with status epilepticus. Neurology 2011; 76: 1252-1255.
70. Dale RC, Merheb V, Pillai S, et al. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain 2012; 135 (Pt 11): 3453-3468.
71. Dale RC, Church AJ, Surtees RA, et al. Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. Brain 2004; 127 (Pt 1): 21-33.
72. Solomon T,. Flavivirus encephalitis. N. Engl. J. Med. 2004; 351: 370-378.
73. Hacohen Y, Deiva K, Pettingill P, et al. N-methyl-D-aspartate receptor antibodies in post-herpes simplex virus encephalitis neurological relapse. Mov. Disord. 2014; 29: 90-96.
74. Mohammad SS, Sinclair K, Pillai S, et al. Herpes simplex encephalitis relapse with chorea is associated with autoantibodies to N-Methyl-D-aspartate receptor or dopamine-2 receptor. Mov. Disord. 2014; 29: 117-122.
75. Chhour YM, Ruble G, Hong R, et al. Hospital-based diagnosis of hemorrhagic fever, encephalitis, and hepatitis in Cambodian children. Emerg. Infect. Dis. 2002; 8: 485-489.
76. Rantakallio P, Leskinen M, von Wendt L,. Incidence and prognosis of central nervous system infections in a birth cohort of 12 000 children. Scand. J. Infect. Dis. 1986; 18: 287-294.
77. Leake JA, Albani S, Kao AS, et al. Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features. Pediatr. Infect. Dis. J. 2004; 23: 756-764.
78. Wang IJ, Lee PI, Huang LM, Chen CJ, Chen CL, Lee WT,. The correlation between neurological evaluations and neurological outcome in acute encephalitis: a hospital-based study. Eur. J. Paediatr. Neurol. 2007; 11: 63-69.
79. Klein SK, Hom DL, Anderson MR, Latrizza AT, Toltzis P,. Predictive factors of short-term neurologic outcome in children with encephalitis. Pediatr. Neurol. 1994; 11: 308-312.
80. Vial C, Pozzetto B, Essid A, Stephan JL, Chabrier S,. Acute encephalitis: report on 32 consecutive pediatric cases observed in one hospital. Med. Mal. Infect. 2007; 37: 208-214.
81. Rayamajhi A, Singh R, Prasad R, Khanal B, Singhi S,. Study of Japanese encephalitis and other viral encephalitis in Nepali children. Pediatr. Int. 2007; 49: 978-984.
82. Rayamajhi A, Singh R, Prasad R, Khanal B, Singhi S,. Clinico-laboratory profile and outcome of Japanese encephalitis in Nepali children. Ann. Trop. Paediatr. 2006; 26: 293-301.
83. Koskiniemi M, Rantalaiho T, Piiparinen H, et al. Infections of the central nervous system of suspected viral origin: a collaborative study from Finland. J. Neurovirol. 2001; 7: 400-408.
84. Le VT, Phan TQ, Do QH, et al. Viral etiology of encephalitis in children in southern Vietnam: results of a one-year prospective descriptive study. PLoS Negl. Trop. Dis. 2010; 4: e854.
85. Khetsuriani N, Holman RC, Anderson LJ,. Burden of encephalitis-associated hospitalizations in the United States, 1988-1997. Clin. Infect. Dis. 2002; 35: 175-182.
86. Davison KL, Crowcroft NS, Ramsay ME, Brown DWG, Andrews NJ,. Viral encephalitis in England, 1989-1998: what did we miss? Emerg. Infect. Dis. 2003; 9: 234-240.
87. Tenembaum S, Chitnis T, Ness J, Hahn JS,. Acute disseminated encephalomyelitis. Neurology 2007; 68 (16 Suppl. 2): S23-36.
88. Huppatz C, Kelly PM, Levi C, Dalton C, Williams D, Durrheim DN,. Encephalitis in Australia, 1979-2006: trends and aetiologies. Commun. Dis. Intell. 2009; 33: 192-197.
89. Huppatz C, Durrheim DN, Levi C, et al. Etiology of encephalitis in Australia, 1990-2007. Emerg. Infect. Dis. 2009; 15: 1359-1365.
90. Hacohen Y, Wright S, Waters P, et al. Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens. J. Neurol. Neurosurg. Psychiatry 2013; 84: 748-755.
91. Dale RC, Brilot F, Fagan E, Earl J,. Cerebrospinal fluid neopterin in paediatric neurology: a marker of active central nervous system inflammation. Dev. Med. Child Neurol. 2009; 51: 317-323.
92. Sinclair AJ, Wienholt L, Tantsis E, Brilot F, Dale RC,. Clinical association of intrathecal and mirrored oligoclonal bands in paediatric neurology. Dev. Med. Child Neurol. 2013; 55: 71-75.
93. Kneen R, Jakka S, Mithyantha R, Riordan A, Solomon T,. The management of infants and children treated with aciclovir for suspected viral encephalitis. Arch. Dis. Child. 2010; 95: 100-106.
94. Solomon T, Michael BD, Smith PE, et al. Management of suspected viral encephalitis in adults-Association of British Neurologists and British Infection Association National Guidelines. J. Infect. 2012; 64: 347-373.
95. Debiasi RL, Tyler KL,. Molecular methods for diagnosis of viral encephalitis. Clin. Microbiol. Rev. 2004; 17: 903-925, table of contents.
96. Bloch KC, Glaser C,. Diagnostic approaches for patients with suspected encephalitis. Curr. Infect. Dis. Rep. 2007; 9: 315-322.
97. Whitley RJ, Alford CA, Hirsch MS, et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N. Engl. J. Med. 1986; 314: 144-149.
98. Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis. 2008; 47: 303-327.
99. James SH, Kimberlin DW, Whitley RJ,. Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection. Antiviral Res. 2009; 83: 207-213.
100. Schleich K, Nurnberger C, Sobanski A, Efferth T,. Vaccination and antiviral treatment of neglected diseases caused by flaviviral infections. Curr. Med. Chem. 2011; 18: 604-614.
101. Shang L, Xu M, Yin Z,. Antiviral drug discovery for the treatment of enterovirus 71 infections. Antiviral Res. 2013; 97: 183-194.
102. Solomon T, Dung NM, Wills B, et al. Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial. Lancet 2003; 361: 821-826.
103. Kamei S, Sekizawa T, Shiota H, et al. Evaluation of combination therapy using aciclovir and corticosteroid in adult patients with herpes simplex virus encephalitis. J. Neurol. Neurosurg. Psychiatry 2005; 76: 1544-1549.
104. Martinez-Torres F, Menon S, Pritsch M, et al. Protocol for German trial of Acyclovir and corticosteroids in Herpes-simplex-virus-encephalitis (GACHE): a multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial [ISRCTN45122933]. BMC Neurol. 2008; 8: 40.
105. Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T,. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010; 9: 1097-1105.
106. Kneen R, Michael BD, Menson E, et al. Management of suspected viral encephalitis in children-Association of British Neurologists and British Paediatric Allergy, Immunology and Infection Group national guidelines. J. Infect. 2012; 64: 449-477.
107. Steiner I, Budka H, Chaudhuri A, et al. Viral meningoencephalitis: a review of diagnostic methods and guidelines for management. Eur. J. Neurol. 2010; 17: 999-e57.
108. Fowler A, Stodberg T, Eriksson M, Wickstrom R,. Long-term outcomes of acute encephalitis in childhood. Pediatrics 2010; 126: e828-835.
109. Michaeli O, Kassis I, Shachor-Meyouhas Y, Shahar E, Ravid S,. Long-term motor and cognitive outcome of acute encephalitis. Pediatrics 2014; 133: e546-552.
110. National Tuberculosis Advisory C. The BCG vaccine: information and recommendations for use in Australia. Commun. Dis. Intell. 2006; 30: 109-115.
111. Communicable Diseases Network of Australia, DoH, Australia. Rabies Virus and Other Lyssavirus (Including Australian Bat Lyssavirus) Exposures and Infections. Canberra, 2013. Available from: http://www.health.gov.au/internet/main/publishing.nsf/Content/cdna-song-abvl-rabies.htm [accessed April 2013].
112. Publication WHO. Rabies vaccines: WHO position paper-recommendations. Vaccine 2010; 28: 7140-7142.
113. Paterson BJ, Mackenzie JS, Durrheim DN, Smith D,. A review of the epidemiology and surveillance of viral zoonotic encephalitis and the impact on human health in Australia. N. S. W. Public Health Bull. 2011; 22: 99-104.